(Q51958283)

English

Combination treatment with IL-2 and anti-IL-2 mAbs reduces tumor metastasis via NK cell activation.

scientific article published on 30 April 2008

Statements

Combination treatment with IL-2 and anti-IL-2 mAbs reduces tumor metastasis via NK cell activation. (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit